參考文獻/References:
[1] 中國抗癌協(xié)會乳腺癌診治指南與規(guī)范(2019版)[J].中國癌癥雜志,2019,29(8):609-680.
[2] 張丹華,唐中華,周琴,等.乳腺癌患者術(shù)后生命質(zhì)量及影響因素的調(diào)查研究[J].現(xiàn)代生物醫(yī)學進展,2014,14(14): 2686-2689.
[3] Han M S, Khan S A.Clinical trials for ductal carcinoma in situ of the breast [J].Journal of Mammary Gland Biology and Neoplasia,2018,23(4): 293-301.
[4] Watanable T,Yamaguchi T,Tsunoda H,et al.Ultrasound image classification of ductal carcinoma in situ(DCIS)of the breast analysis of 705 DCIS lesions[J].Ultrasound Med Biol,2017,43(5):918.
[5] Adler D D,Carson P L,Rubin J M,et al.Doppler ultrasound color flow imaging in the study of breast cancer:preliminary findings [J].Ultrasound Med Biol,1990,16(6):553-559.
[6] 何年安.2013版超聲乳腺影像報告及數(shù)據(jù)系統(tǒng)分級解讀與臨床應用新進展[J].安徽醫(yī)學,2015,36(11):1424-1427.
[7] Fan L,Strasser-Weipp K,Li J J,et al.Breast cancer in China[J].Lancet Oncol,2014,15(7):279-289.
[8] Siegel R L,Miller K D,Jemal A.Cancer statistics,2016[J].CA Cancer J Clin,2016,66(1):7-30.
[9] Bianchini G,Balko J M,Mayer I A,et al.Triple-negative breast cancer:challenges and opportunities of a heterogeneous disease[J].Nat Rev Clin Oncol,2016,13(11):674-690.
[10] Koh V C Y, Lim J C T,Thike A A,et al.Behaviour and characteristics of low-grade ductal carcinoma in situ of the breast:literature review and single-centre retrospective series[J].Histopathology,2019,74(7):970-987.
[11] Yao J J,Zhan W W,Chen M,et al.Sonographic Features of ductal carcinoma in situ of the breast with microinvasion:correlation with clinicopathologic findings and biomarkers[J].Ultrasound Med,2015,34(10):1761-1768.
[12] 鄭靜,徐金鋒,羅慧.伴后方回聲衰減的乳腺良性病變與乳腺癌的超聲鑒別診斷[J].中華超聲影像學雜志,2014,23(8):728-729.
[13] 胡浩.乳腺癌的彩色多普勒血流分布特征與組織病理學對照分析[J].中國婦幼健康研究,2017,28(4):125-126.
[14] Hofvind S,Iversen B F,Eriksen L,et al.Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening[J].Acta Radiol,2011,52(5):481-487.
[15] 朱麗鈺,婁鑒娟,王思奇,等.乳腺導管原位癌微鈣化X線特征與病理的對照研究[J].放射學實踐,2019,34(11):1237-1241.
相似文獻/References:
[1]林 盈 楊華娟 許小玲 楊 煜 張 韜 王 穎.高頻超聲與雙能量CT聯(lián)合診斷早期痛風性關(guān)節(jié)炎的價值[J].福建醫(yī)藥雜志,2020,42(03):17.
LIN Ying,YANG Huajuan,XU Xiaoling,et al.The value of high-frequency ultrasound combined with dual-energy CT in the diagnosis of early gouty arthritis[J].FUJIAN MEDICAL JOURNAL,2020,42(05):17.
[2]凌 文 翁宗杰 邱秀青 馬 宏吳秋梅 賴遠芳 陳錦文 劉 敏.九切面節(jié)段分析法在胎兒復雜先天性心臟病診斷中的應用價值[J].福建醫(yī)藥雜志,2020,42(06):9.
LING Wen,WENG Zongjie,QIU Xiuqing,et al.Clinical value of nine-section segmental analysis in the diagnosis of complex fetal congenital heart disease[J].FUJIAN MEDICAL JOURNAL,2020,42(05):9.
[3]陳瓊,葉小芬,王康健,等.伴有不同甲狀腺疾病的乳頭狀癌頸中央?yún)^(qū)淋巴結(jié)轉(zhuǎn)移預測模型建立與驗[J].福建醫(yī)藥雜志,2023,45(06):4.
CHEN Qiong,YE Xiaofen,WANG Kangjian,et al.Prediction of papillary thyroid metastases to the central compartment: proposal of a model taking into consideration other thyroid conditions[J].FUJIAN MEDICAL JOURNAL,2023,45(05):4.
[4]林建婷,邱思花,張玲潔,等.妊娠期卵巢透明細胞癌1例超聲誤診分析[J].福建醫(yī)藥雜志,2024,46(04):118.[doi:10.20148/j.fmj.2024.04.034]
[5]黃蓓蕾,王月桂,陳紅,等.PR基因表達聯(lián)合超聲影像構(gòu)建HER2陰性乳腺癌腋窩淋巴結(jié)轉(zhuǎn)移預測模型及應用[J].福建醫(yī)藥雜志,2024,46(08):1.[doi:10.20148/j.fmj.2024.08.001]
HUANG Beilei,WANG Yuegui,CHEN Hong,et al.Prediction model of axillary lymph node metastasis in HER2 negative breast cancer by PR gene expression combined with ultrasound image and its application[J].FUJIAN MEDICAL JOURNAL,2024,46(05):1.[doi:10.20148/j.fmj.2024.08.001]